Ellen Lin, MD
Pain Medicine · San Antonio, TXNPI 1548273501
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 61.4% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2019 at $52,743 and has fallen 85.6% since, to $7,608 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,488 payments — averaging $79.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$72K
- Stimwave Technologies Incorporated$11K
- Globus Medical$6K
- Biohaven Pharmaceuticals, Inc.$6K
- Teva Pharmaceuticals USA, Inc.$4K
- Curonix LLC$3K
- plus $16K from 54 others
Across 61 payments — averaging $2535.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$135K
- Curonix LLC$13K
- Boston Scientific$3K
- Globus Medical$3K
- Saluda Medical Americas, Inc.$45
What the payments were for
- Consulting fees$10,8059%
- Speaking & faculty fees$47,40040%
- Travel & lodging$13,71412%
- Food & beverage$44,30538%
- Education$1970%
- Gifts$2390%
- Entertainment$1,3661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$49,625
- NURTEC ODT$7,370
- Omnia$7,108
- Senza$6,632
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$3,075
- StimQ Receiver Stimulator Kit Channel A US w Receiver$2,107
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$2,107
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$2,107
- Freedom 4A Receiver Kit Channel A US w Receiver$2,107
- Freedom 8A Receiver Kit Channel A US w Receiver$2,107
- Vyrsa V1$1,746
- CFNS StimQ Peripheral Nerve StimulatorSystem$1,450
- SCS FreedonSpinal Cord Stimulator$1,450
- UBRELVY$1,300
- AJOVY$1,125
- mild Device Kit$1,039
- RAYOS$750
- InSpan$682
- Sacrix$682
- TenJet$495
How this compares
$118,027 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 99 | $174,579 |
| Nucynta ErTapentadol Hcl | 52 | $104,438 |
| BelbucaBuprenorphine Hcl | 73 | $53,865 |
| Nurtec OdtRimegepant Sulfate | 19 | $34,356 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 975 | $25,090 |
| Buprenorphine | 30 | $11,055 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 127 | $3,332 |
| Baclofen | 197 | $2,243 |
| Tramadol Hcl ErTramadol Hcl | 32 | $2,058 |
| Pregabalin | 111 | $1,881 |
| Gabapentin | 152 | $1,721 |
| Methocarbamol | 67 | $1,378 |
| Lidocaine | 17 | $1,346 |
| Fentanyl | 15 | $1,252 |
| Tramadol Hcl | 182 | $1,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Nucynta Er, Belbuca | $1,204 | $332,882224 claims |
| PfizerNurtec Odt | $528 | $34,35619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 pain medicine providers in Texas.
Other pain medicine in San Antonio
- Prabhdeep GrewalSan Antonio$48K
- Roberto DiazSan Antonio$37K
- Ricardo AlvaradoSan Antonio$23K
- Charles BryantSan Antonio$23K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.